BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26973229)

  • 1. Generation of E. coli-derived virus-like particles of porcine circovirus type 2 and their use in an indirect IgG enzyme-linked immunosorbent assay.
    Zhang Y; Wang Z; Zhan Y; Gong Q; Yu W; Deng Z; Wang A; Yang Y; Wang N
    Arch Virol; 2016 Jun; 161(6):1485-91. PubMed ID: 26973229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
    Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and application of a competitive enzyme-linked immunosorbent assay differentiating PCV2 antibodies from mixture of PCV1/PCV2 antibodies in pig sera.
    Han S; Xiao Y; Zheng D; Gu Y; Xuan Y; Jin Y; Pang W; Huang Y; Li X; Deng J; Tian K
    BMC Vet Res; 2016 Aug; 12(1):175. PubMed ID: 27561335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
    Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
    Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
    Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
    Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
    He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
    Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanobody-horseradish peroxidase fusion protein-based competitive ELISA for rapid detection of antibodies against porcine circovirus type 2.
    Mu Y; Jia C; Zheng X; Zhu H; Zhang X; Xu H; Liu B; Zhao Q; Zhou EM
    J Nanobiotechnology; 2021 Feb; 19(1):34. PubMed ID: 33526021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation.
    Xi X; Mo X; Xiao Y; Yin B; Lv C; Wang Y; Sun Z; Yang Q; Yao Y; Xuan Y; Li X; Yuan YA; Tian K
    J Biotechnol; 2016 Apr; 223():8-12. PubMed ID: 26907669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
    Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
    Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
    Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
    Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.
    Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2.
    Shang SB; Li YF; Guo JQ; Wang ZT; Chen QX; Shen HG; Zhou JY
    Res Vet Sci; 2008 Feb; 84(1):150-7. PubMed ID: 17467754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome.
    Blanchard P; Mahé D; Cariolet R; Truong C; Le Dimna M; Arnauld C; Rose N; Eveno E; Albina E; Madec F; Jestin A
    Vet Microbiol; 2003 Jul; 94(3):183-94. PubMed ID: 12814886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
    Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
    Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.